Activation of NF-κB is required for mediating proliferative and antiapoptotic effects of progastrin on proximal colonic crypts of mice, in vivo

S. Umar, S. Sarkar, S. Cowey, Pomila Singh

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Mice overexpressing progastrin (PG) in intestinal mucosa (fatty acid-binding protein (Fabp)-PG mice) are at an increased risk of proximal colon carcinogenesis in response to azoxymethane. Here, we report a significant increase in the length of proximal colonic crypts in Fabp-PG mice, associated with potent antiapoptotic effects of PG, which likely contributed to the previously reported increase in colon carcinogenesis in Fabp-PG mice. Phosphorylation of kinase of IκBα (IKKα/β), inhibitor of κB (IκB)α and p65NF-κB was significantly elevated in proximal colonic crypts of Fabp-PG versus wild-type mice, which was associated with degradation of IκBα and nuclear translocation/activation of p65. Surprisingly, distal colonic crypt cells were not as responsive to elevated levels of PG in Fabp-PG mice. Annexin II, recently described as a high-affinity receptor for PG, strongly co-localized with PG intracellularly and on basolateral membranes of proximal crypt cells, providing evidence that annexin-II binds PG in situ in colonic crypt cells. Proliferative and antiapoptotic effects of PG on proximal crypts of Fabp-PG mice were attenuated to wild-type levels, on treatment with NEMO peptide (an inhibitor of nuclear factor-κB (NF-κB) activation), demonstrating for the first time a critical role of NF-κB in mediating hyperproliferative affects of PG on colonic crypts of Fabp-PG mice, in vivo. Thus, downregulation of NF-κB may significantly reduce the increased risk of colon carcinogenesis in response to PG.

Original languageEnglish (US)
Pages (from-to)5599-5611
Number of pages13
JournalOncogene
Volume27
Issue number42
DOIs
StatePublished - Sep 18 2008

Fingerprint

Fatty Acid-Binding Proteins
Annexin A2
Colon
Carcinogenesis
big gastrin
Azoxymethane
Intestinal Mucosa
Phosphotransferases
Down-Regulation
Phosphorylation
Peptides
Membranes

Keywords

  • Annexin II
  • ERKs
  • Fabp-PG mice
  • NEMO
  • NFκB
  • Progastrin

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Activation of NF-κB is required for mediating proliferative and antiapoptotic effects of progastrin on proximal colonic crypts of mice, in vivo. / Umar, S.; Sarkar, S.; Cowey, S.; Singh, Pomila.

In: Oncogene, Vol. 27, No. 42, 18.09.2008, p. 5599-5611.

Research output: Contribution to journalArticle

@article{62a823045ce14236a46b830758a8534f,
title = "Activation of NF-κB is required for mediating proliferative and antiapoptotic effects of progastrin on proximal colonic crypts of mice, in vivo",
abstract = "Mice overexpressing progastrin (PG) in intestinal mucosa (fatty acid-binding protein (Fabp)-PG mice) are at an increased risk of proximal colon carcinogenesis in response to azoxymethane. Here, we report a significant increase in the length of proximal colonic crypts in Fabp-PG mice, associated with potent antiapoptotic effects of PG, which likely contributed to the previously reported increase in colon carcinogenesis in Fabp-PG mice. Phosphorylation of kinase of IκBα (IKKα/β), inhibitor of κB (IκB)α and p65NF-κB was significantly elevated in proximal colonic crypts of Fabp-PG versus wild-type mice, which was associated with degradation of IκBα and nuclear translocation/activation of p65. Surprisingly, distal colonic crypt cells were not as responsive to elevated levels of PG in Fabp-PG mice. Annexin II, recently described as a high-affinity receptor for PG, strongly co-localized with PG intracellularly and on basolateral membranes of proximal crypt cells, providing evidence that annexin-II binds PG in situ in colonic crypt cells. Proliferative and antiapoptotic effects of PG on proximal crypts of Fabp-PG mice were attenuated to wild-type levels, on treatment with NEMO peptide (an inhibitor of nuclear factor-κB (NF-κB) activation), demonstrating for the first time a critical role of NF-κB in mediating hyperproliferative affects of PG on colonic crypts of Fabp-PG mice, in vivo. Thus, downregulation of NF-κB may significantly reduce the increased risk of colon carcinogenesis in response to PG.",
keywords = "Annexin II, ERKs, Fabp-PG mice, NEMO, NFκB, Progastrin",
author = "S. Umar and S. Sarkar and S. Cowey and Pomila Singh",
year = "2008",
month = "9",
day = "18",
doi = "10.1038/onc.2008.169",
language = "English (US)",
volume = "27",
pages = "5599--5611",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "42",

}

TY - JOUR

T1 - Activation of NF-κB is required for mediating proliferative and antiapoptotic effects of progastrin on proximal colonic crypts of mice, in vivo

AU - Umar, S.

AU - Sarkar, S.

AU - Cowey, S.

AU - Singh, Pomila

PY - 2008/9/18

Y1 - 2008/9/18

N2 - Mice overexpressing progastrin (PG) in intestinal mucosa (fatty acid-binding protein (Fabp)-PG mice) are at an increased risk of proximal colon carcinogenesis in response to azoxymethane. Here, we report a significant increase in the length of proximal colonic crypts in Fabp-PG mice, associated with potent antiapoptotic effects of PG, which likely contributed to the previously reported increase in colon carcinogenesis in Fabp-PG mice. Phosphorylation of kinase of IκBα (IKKα/β), inhibitor of κB (IκB)α and p65NF-κB was significantly elevated in proximal colonic crypts of Fabp-PG versus wild-type mice, which was associated with degradation of IκBα and nuclear translocation/activation of p65. Surprisingly, distal colonic crypt cells were not as responsive to elevated levels of PG in Fabp-PG mice. Annexin II, recently described as a high-affinity receptor for PG, strongly co-localized with PG intracellularly and on basolateral membranes of proximal crypt cells, providing evidence that annexin-II binds PG in situ in colonic crypt cells. Proliferative and antiapoptotic effects of PG on proximal crypts of Fabp-PG mice were attenuated to wild-type levels, on treatment with NEMO peptide (an inhibitor of nuclear factor-κB (NF-κB) activation), demonstrating for the first time a critical role of NF-κB in mediating hyperproliferative affects of PG on colonic crypts of Fabp-PG mice, in vivo. Thus, downregulation of NF-κB may significantly reduce the increased risk of colon carcinogenesis in response to PG.

AB - Mice overexpressing progastrin (PG) in intestinal mucosa (fatty acid-binding protein (Fabp)-PG mice) are at an increased risk of proximal colon carcinogenesis in response to azoxymethane. Here, we report a significant increase in the length of proximal colonic crypts in Fabp-PG mice, associated with potent antiapoptotic effects of PG, which likely contributed to the previously reported increase in colon carcinogenesis in Fabp-PG mice. Phosphorylation of kinase of IκBα (IKKα/β), inhibitor of κB (IκB)α and p65NF-κB was significantly elevated in proximal colonic crypts of Fabp-PG versus wild-type mice, which was associated with degradation of IκBα and nuclear translocation/activation of p65. Surprisingly, distal colonic crypt cells were not as responsive to elevated levels of PG in Fabp-PG mice. Annexin II, recently described as a high-affinity receptor for PG, strongly co-localized with PG intracellularly and on basolateral membranes of proximal crypt cells, providing evidence that annexin-II binds PG in situ in colonic crypt cells. Proliferative and antiapoptotic effects of PG on proximal crypts of Fabp-PG mice were attenuated to wild-type levels, on treatment with NEMO peptide (an inhibitor of nuclear factor-κB (NF-κB) activation), demonstrating for the first time a critical role of NF-κB in mediating hyperproliferative affects of PG on colonic crypts of Fabp-PG mice, in vivo. Thus, downregulation of NF-κB may significantly reduce the increased risk of colon carcinogenesis in response to PG.

KW - Annexin II

KW - ERKs

KW - Fabp-PG mice

KW - NEMO

KW - NFκB

KW - Progastrin

UR - http://www.scopus.com/inward/record.url?scp=52149104026&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52149104026&partnerID=8YFLogxK

U2 - 10.1038/onc.2008.169

DO - 10.1038/onc.2008.169

M3 - Article

VL - 27

SP - 5599

EP - 5611

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 42

ER -